Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Post by teeveeon Aug 23, 2010 1:39pm
697 Views
Post# 17375226

financing already lined up

financing already lined upI suspect ISA will finance by selling a royalty to one of the director's companies. The director, David MacNaughtan is a principle at Patent Pending Capital Advisors, and VP and co-head of Royalty Montization Fund of DRI Capital. What will be left for ISA and its shareholders? 
<< Previous
Bullboard Posts
Next >>